Botanicure Co., LTD.
June 24, 2026
Theater 4
Type: Company Presentation
Focus Area:
Brain Health
Botanicure Biopharmaceutical Co., Ltd. (Botanicure) was established in 2002. Its R&D center is in the Tainan Science Park, while its operation headquarters is based in Phase III of the Nanang Software Park. The company is deeply engaged in the development of botanical new drugs, focusing on addressing major unmet medical needs, including dementia, difficult-to-treat skin conditions (such as diabetic foot ulcer and radiation-induced skin injuries). Botanicure is the first company worldwide to complete a U.S. FDA Phase IIa clinical trial for a botanical new drug targeting dementia. The company continues to expand into multiple neurological and aging-related disease areas, demonstrating strong R&D leadership and international outlook. Botanicure firmly believes that botanical new drugs are not merely a niche market, but will become a mainstream segment of future global healthcare.
Company HQ City:
Taipei City
Company HQ State:
Taipei
Company HQ Country:
Taiwan
Year Founded:
2002
CEO
Yi Sheng Hsu
Primary Speaker
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}